Selling Blue Water Biotech Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders

PBLADelisted Stock  USD 2.06  0.11  5.07%   
About 62% of Panbela Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Panbela Therapeutics stock suggests that many investors are alarmed at this time. The current market sentiment, together with Panbela Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Panbela Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Even though Blue Water Biotech, Inc. has fallen by 11 percent over the past week , insiders who sold US2.6m...

Read at simplywall.st
Simply Wall St News at Macroaxis
  

Panbela Therapeutics Fundamental Analysis

We analyze Panbela Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Panbela Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Panbela Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Panbela Therapeutics is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Panbela Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Panbela Therapeutics stock to make a market-neutral strategy. Peer analysis of Panbela Therapeutics could also be used in its relative valuation, which is a method of valuing Panbela Therapeutics by comparing valuation metrics with similar companies.

Peers

Panbela Therapeutics Related Equities

CDIOCardio Diagnostics   9.26   
0%
44.0%
KPRXKiora Pharmaceuticals   3.41   
0%
16.0%
QNRXQuoin Pharmaceuticals   0.14   
0%
1.0%
ZVSAZyVersa Therapeutics   0.00   
0%
0%
VRAXVirax Biolabs   1.63   
7.0%
0%
UNCYUnicycive Therapeutics   2.38   
11.0%
0%
SONNSonnet Biotherapeutics   5.71   
27.0%
0%
REVBRevelation Biosciences   5.76   
27.0%
0%
CYTOAltamira Therapeutics   6.12   
29.0%
0%
PALIPalisade Bio   20.88   
100.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Consideration for investing in Panbela Stock

If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios